VTR · Ventas, Inc.
$92.92
-0.58 (-0.62%)
At close · Aug 27
Market Cap
$47.96B
Shares
512.95M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$93.50
Open$93.94
Day$93.22–94.50
52W close$67.13–100.53
Avg vol 30d3.3M
Short int23.7M · 4.6% float · 7.6d
Short vol64%
Last earningsJul 30, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 30, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Neutral
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very Low
Market backdrop
VIX 15.2 · calm
Equity put/call 0.64
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+10%
above
Price vs 50-day avg
+2%
above
RSI (14)
54
neutral
MACD trend
Positive
52-week position
79%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−4%
trailing
6-month return
+10%
trailing
YTD return
+21%
this year
Relative strength
−2%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $92 › 200d $85 — 50d above 200d
Institutional flow
Accumulating
+1% holders QoQ · +109 funds added
Insider flow
Accumulating
Net +$197.0K over 90 days · 0% sells
Short interest
Rising
4.62% of float · ▲ +0.1% MoM · 7.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
949 holders — near 3-yr high, broad support
Squeeze score
62
elevated · 0–100
Fundamentals
Revenue growth
+18%
Y/Y
EPS growth
+184%
Y/Y
Free cash flow
$1.5B
Valuation
P/E 173.2
rich
Balance sheet
$12.3B
net debt
Quant / Vol
risk profile
Volatility
22%
annualized · 1-yr
Max drawdown
−14%
past year
ATR
2.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 29, 2026
Full Year 2026
Attributable Net Income Per Share Range
Initiated
$0.58 – $0.63
prior FY $0.54
midpoint +12.0% Y/Y
Nareit FFO Per Share Range
Initiated
$3.76 – $3.81
Normalized FFO Per Share Range
Initiated
$3.85 – $3.90
Investment volume (senior housing investments)
Initiated
$4.5B
Disposition and loan repayment proceeds
Initiated
$700M
Interest expense
Initiated
$646M
Interest and other income
Initiated
$8M
FY 2026
Investments focused on senior housing
Initiated
$4.5B
FAD capital expenditures
Initiated
$400M
Prior guidance
period ended
· from the 8-K filed Oct 29, 2025
Attributable Net Income Per Share Range
· Full Year 2025
$0.49 – $0.52
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+10%
Bullish
Price vs 50-day avg
+2%
Bullish
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
79%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $92 › 200d $85 — 50d above 200d
Institutional flow
Accumulating
+1% holders QoQ · +109 funds added
Insider flow
Accumulating
Net +$197.0K over 90 days · 0% sells
Short interest
Rising
4.62% of float · ▲ +0.1% MoM · 7.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
949 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $67
Now $94 · 79%
Range high $101
vs 200-day avg +10%
vs 50-day avg +2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $663.06M | six months ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income attributable to common stockholders $70.57M
+$160.03M Interest expense
+$83K Loss on extinguishment of debt, net
-$24.43M Taxes (including tax amounts in general, administrative and professional fees)
+$407.71M Depreciation and amortization
+$5.31M Non-cash stock-based compensation expense
+$13.48M Transaction, transition and restructuring costs
-$10.96M Net income attributable to noncontrolling interests, adjusted for partners' share of consolidated entity EBITDA
+$42.32M Income from unconsolidated entities, adjusted for Ventas' share of EBITDA from unconsolidated entities
-$176K Gain on real estate dispositions
+$183K Unrealized foreign currency gain (loss)
+$0K Gain on derivatives, net
-$1.06M Significant disruptive events, net
+$0K Other normalizing items, net
= Adjusted EBITDA $663.06M
|
|||
| Further Adjusted EBITDA non-GAAP | $683.71M | six months ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Adjusted EBITDA $663.06M
+$20.65M Adjustment for current period activity
= Further Adjusted EBITDA $683.71M
|
|||
| Further Adjusted EBITDA annualized non-GAAP | $2.73B | six months ended June 30, 2026 | — |
| Net Debt non-GAAP | $12.91B | as of June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Total Debt $12.69B
-$198.96M Cash and cash equivalents
-$2.64M Restricted cash pertaining to debt
-$335.87M Partners' share of consolidated debt
+$755.82M Ventas's share of unconsolidated debt
= Net Debt $12.91B
|
|||
| Net Debt / Further Adjusted EBITDA non-GAAP | 4.7 | as of June 30, 2026 | — |
| Normalized FFO attributable to common stockholders per share non-GAAP | $0.97 | Q2 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Nareit FFO attributable to common stockholders per share $0.99
-$0.02 Subtotal: Normalized FFO adjustments per share
= Normalized FFO attributable to common stockholders per share $0.97
|
|||
| RevPOR growth non-GAAP | 5% | second quarter 2026 | — |
|
|
|||
| Same-Store Cash NOI margin expansion non-GAAP | 210 | second quarter 2026 | — |
| Same-Store Cash NOI percentage increase (NNN) non-GAAP | 3.1% | Q2 FY2026 | — |
| Same-Store Cash NOI percentage increase (OM&R) non-GAAP | 4.6% | Q2 FY2026 | — |
| Same-Store Cash NOI percentage increase (SHOP) non-GAAP | 16.3% | Q2 FY2026 | — |
| Same-Store Cash NOI percentage increase (Total) non-GAAP | 10.3% | Q2 FY2026 | — |
| Same-Store Cash Operating Revenue growth non-GAAP | 9% | second quarter 2026 | — |
| Same-Store Cash Operating Revenue percentage increase Seq non-GAAP | 0.8% | Q2 FY2026 | — |
| Same-Store Cash Operating Revenue percentage increase YoY non-GAAP | 8.6% | Q2 FY2026 | — |
| SHOP Same-Store Cash NOI non-GAAP | 16% | second quarter 2026 | — |
| Subtotal: Normalized FFO adjustments per share non-GAAP | -$0.02 | Q2 FY2026 | — |
| U.S. SHOP Same-Store Cash NOI non-GAAP | 18% | second quarter 2026 | — |
| Common stock shares settled under equity forward sales agreements | 10.6M | Q1 2026 | — |
| Liquidity | 5.5B | Q1 2026 | — |
| Net proceeds from settled equity forward sales agreements | 0.8B | Q1 2026 | — |
| Senior housing investments closed in Q1 | 1B | Q1 2026 | — |
| Senior housing investments closed year to date | 1.7B | Q1 2026 | — |
| SHOP Same-Store NOI margin expansion non-GAAP | 170 | Q1 2026 | — |
| Total Company Same-Store Cash NOI year-over-year growth non-GAAP | 9% | Q1 2026 | — |
| Total equity capital raised | 2.4B | Q1 2026 | — |
| Total SHOP Same-Store average occupancy growth non-GAAP | 310 | Q1 2026 | — |
| U.S. SHOP Same-Store average occupancy growth non-GAAP | 370 | Q1 2026 | — |
| Unsettled equity forward sales agreements outstanding | 1.6B | Q1 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VTR
this stock
Ventas, Inc.
|
$47.96B | +20.8% | +18.5% | 173.2 | 4.6% |
|
WELL
Welltower Inc.
|
$170.52B | +30.1% | +35.6% | 120.2 | 2.5% |
|
DOC
Healthpeak Properties, Inc.
|
$14.66B | +34.2% | +4.5% | 60.7 | 3.3% |
|
OHI
Omega Healthcare Investors Inc
|
$14.25B | +5.9% | +13.2% | 16.7 | 4.0% |
|
AHR
American Healthcare REIT, Inc.
|
$12.46B | +21.5% | +9.1% | 82.8 | 13.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VTR | +1.8% | -4.3% | +10.1% | 0.0% | +20.8% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | +2.2% | -9.3% | -2.4% | -2.6% | +8.5% |
Capital returns
Latest dividend
$0.52
/ share · ex Jun 30, 2026
Paid (TTM)
$2.00
/ share · 4 payouts
Dividend yield (TTM, derived)
2.14%
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
740260
CUSIP
92276F100
13F (30d)
687 filings
681 filers
Visit website
Investor relations